HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mark Van Buskirk Selected Research
Mark Van Buskirk Research Topics
Disease
5
Colorectal Neoplasms (Colorectal Cancer)
12/2018 - 12/2005
5
Neoplasm Metastasis (Metastasis)
12/2018 - 12/2005
5
Hepatocellular Carcinoma (Hepatoma)
01/2018 - 11/2004
4
Neoplasms (Cancer)
12/2018 - 11/2004
2
Ascites
09/2011 - 12/2005
2
Liver Neoplasms (Liver Cancer)
09/2011 - 11/2004
1
Cystic Fibrosis (Mucoviscidosis)
04/2022
1
Adenocarcinoma
01/2017
1
Disease Progression
01/2016
1
Liver Failure
12/2005
1
Liver Diseases (Liver Disease)
12/2005
1
Pleural Effusion (Pleural Effusions)
12/2005
1
Gastritis
12/2005
Drug/Important Bio-Agent (IBA)
4
Yttrium-90
IBA
01/2016 - 11/2004
3
Sirtuins
IBA
12/2018 - 12/2014
3
Oxaliplatin (Eloxatin)
FDA Link
Generic
12/2018 - 12/2014
3
Yttrium
IBA
01/2017 - 02/2005
2
Fluorouracil (Carac)
FDA Link
Generic
12/2018 - 01/2016
2
Leucovorin (Folinic Acid)
FDA Link
12/2018 - 01/2016
2
Bevacizumab (Avastin)
FDA Link
01/2017 - 01/2016
2
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
09/2011 - 11/2004
1
Enzymes
IBA
04/2022
1
Carcinoembryonic Antigen
IBA
01/2017
1
Indicators and Reagents (Reagents)
IBA
01/2017
1
Bilirubin
IBA
09/2011
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
12/2005
Therapy/Procedure
7
Microspheres (Microsphere)
01/2016 - 11/2004
4
Drug Therapy (Chemotherapy)
12/2018 - 12/2005
3
Radiotherapy
12/2018 - 12/2014
2
Therapeutics
01/2018 - 12/2005
1
Enteral Nutrition (Feeding, Tube)
04/2022
1
Combined Modality Therapy
01/2018
1
Aftercare (After-Treatment)
12/2005
1
Intra-Arterial Injections
02/2005